Screener
Aurinia Pharmaceuticals AUPH Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from issuance of common shares under ESPP | 363 | 401 |
| Tax withholding payments related to net settlements of equity awards | (26,454) | (9,036) |
| Cash flows from financing activities | (48,875) | (93,731) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 99,619 | (30,431) |
| Cash, cash equivalents and restricted cash, beginning of the period | 80,213 | 83,433 |
| Cash, cash equivalents and restricted cash, end of the period | $179,832 | $53,002 |
| Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets: | ||
| Cash and cash equivalents | $179,732 | $52,914 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's net change in cash?
- Aurinia Pharmaceuticals (AUPH) reported net change in cash of $138.82M in Q2 2026.
- How has Aurinia Pharmaceuticals's net change in cash changed year-over-year?
- Aurinia Pharmaceuticals's net change in cash increased by 1134.0% year-over-year, from -$13.43M to $138.82M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Aurinia Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude